Co-trimoxazole [Sulphamethoxazole (A) + Trimethoprim (B)] Oral liquid 200 mg (A) + 40 mg (B)/5 mL (p)

Here’s the full structured profile for the Co-trimoxazole Oral Suspension (Pediatric formulation) 👇


💊 Co-trimoxazole Oral Liquid 200 mg (Sulphamethoxazole) + 40 mg (Trimethoprim) / 5 mL


📘 Description:

A pediatric fixed-dose antibacterial suspension containing:

  • Sulphamethoxazole (A) – 200 mg per 5 mL
    (sulfonamide; inhibits dihydropteroate synthase)
  • Trimethoprim (B) – 40 mg per 5 mL
    (dihydrofolate reductase inhibitor)

The combination inhibits sequential steps of folic acid synthesis, leading to a synergistic bactericidal effect.


📄 Prescription / Indications:

Used in children (and adults unable to swallow tablets) for:

  • Urinary tract infections (UTIs)
  • Respiratory tract infections – bronchitis, otitis media, sinusitis, pneumonia
  • Gastrointestinal infections – shigellosis, traveler’s diarrhea
  • Skin and soft tissue infections
  • Pneumocystis jirovecii pneumonia (PCP) – treatment & prophylaxis in children with HIV/AIDS
  • Toxoplasmosis & Nocardiosis (special situations, in combination)

🌿 Nature / Drug Class:

  • Antibacterial combination
  • Sulfonamide + Diaminopyrimidine
  • Bactericidal (synergistic effect)

Advantages:

  • Broad-spectrum coverage against Gram-positive & Gram-negative bacteria
  • Synergistic action → reduces resistance development
  • Liquid form allows accurate weight-based dosing in pediatrics
  • Widely available and cost-effective

⚠️ Precautions:

Contraindications:

  • Infants <2 months (risk of kernicterus)
  • Sulfonamide or trimethoprim allergy
  • Severe hepatic or renal impairment
  • Late pregnancy & breastfeeding

Use with caution:

  • In patients with folate deficiency
  • Renal impairment → dose adjustment needed
  • HIV-positive children → higher risk of rash, neutropenia

Monitoring (if prolonged use):

  • CBC (risk of bone marrow suppression)
  • Renal & liver function tests

Adverse effects:

  • GI upset (nausea, vomiting, diarrhea)
  • Rash, pruritus, urticaria
  • Rare but serious: Stevens–Johnson syndrome, TEN, aplastic anemia, agranulocytosis
  • Hyperkalemia in prolonged/high-dose therapy

👉 Advise caregivers: Ensure adequate hydration to prevent crystalluria.


📦 Common Packaging:

  • 100 mL or 60 mL bottles with dosing spoon/dropper
  • Pediatric formulation often labeled as Paediatric Suspension

❄️ Storage Conditions:

  • Store at room temperature (<25°C)
  • Protect from light & moisture
  • Once opened, use within the recommended period (usually 7–14 days)
  • Keep out of reach of children

Leave a Comment

Your email address will not be published. Required fields are marked *

Call Now Button